Altimmune, Inc.
ALT· Nasdaq
Released Aug 10, 2023, before the open
10-Q filed Aug 10, 2023, 41 days after period end · 0001326190-23-000036
| Metric | Q2 2023 | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|---|
| Revenue | $6.00K | $8.00K | $137.00K | $721.64K |
| Net Income | -$16.06M | -$20.11M | -$24.83M | -$16.77M |
| EPS Diluted |
Altimmune, Inc. · CIK 1326190 · Engraved from SEC EDGAR
| -$0.32 |
| -$0.42 |
| -$0.60 |
| -$0.94 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.